Citigroup Maintains Buy on BeiGene, Raises Price Target to $288
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Yigal Nochomovitz maintains a Buy rating on BeiGene (NASDAQ:BGNE) and raises the price target from $269 to $288.
August 08, 2024 | 7:12 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup analyst Yigal Nochomovitz maintains a Buy rating on BeiGene and raises the price target from $269 to $288.
The raised price target and maintained Buy rating from a reputable analyst at Citigroup is likely to positively impact BeiGene's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100